Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon
Thumbnail

Private equity firm buys controlling stake in Surescripts

TPG will not own a majority of the e-prescriber, with CVS Health and Express Scripts maintaining a minority stake.

healthcare money economics dollar stethoscope acquire merger

Orlando Health buys 5 Alabama hospitals for $910M

The nonprofit health system purchased the Brookwood Baptist Health network from for-profit Tenet Healthcare, which held a 70% controlling stake.

Medicare Advantage Part C clipboard payment

92% of rural Nebraska hospitals report financial hardship caused by Medicare Advantage plans

Members of the Nebraska Rural Health Association overwhelmingly expressed concerns that Medicare Advantage plans could jeopardize patient health. Some are considering dropping their contracts with the plans altogether. 

Private jet stock photo

UPMC expensed $50M private jet, despite laying off 1,000 workers

Pittsburgh Medical Center CEO Leslie Davis used the jet to travel around the world, flight logs show. 

wisconsin baldwin rural healthcare

HHS awards $75M for addiction and maternal health services in rural areas

The funds will be used to expand services and improve the financial stability of existing healthcare organizations located in underserved regions of the South. 

The FreeClimb 70 reperfusion system with Tenzing 7 delivery catheter. Image courtesy of Route 92 Medical.

Stroke specialists raise another $50M thanks to late investment from Novo Holdings

California-based Route 92 Medical previously announced a funding round worth more than $31 million in November. Now, however, a massive addition from Novo Holdings makes the round worth closer to $82 million. 

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Most recalled cardiovascular devices gained FDA approval with little to no clinical evidence

Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing. 

Money bankruptcy debt liquidation

Atrium Health forgives patient debts, withdraws liens on 11,500 homes

The nonprofit hospital system stopped suing patients in 2022 and called debt cancellation the “next logical step.”

Displaying 1 - 8 of 2282

Around the web

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Cardiovascular Business
Watchdog group, fearful of fraud, wants more oversight for remote patient monitoring

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

Cardiovascular Business
Most recalled cardiovascular devices gained FDA approval with little to no clinical evidence

Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup